Cybersecurity, COVID-19 and EU MDR Hot Topics of the 2020 MedTech Summer
Although the full impact of COVID-19 is uncertain, one sure thing is that industry continues to crave information to help them navigate EU MDR.
Tag Archives: life sciences
The Future of MedTech and Healthcare: No Boundary on Uniting Forces
All industries under the healthcare umbrella should embrace each other’s capabilities because no single category of player can master it and bring to consumers all that we need and demand, says Stephen Bernstein of McDermott Will & Emery.
Playing by the Rules: A Lever for Doing Better Business?
Investments in new processes and systems must satisfy the needs of the authorities and ensure patient safety and public confidence. Getting it right is likely to be expensive. but regulatory compliance shouldn’t be viewed purely as a cost center.
Full Economic Impact of COVID-19 on Life Sciences Industry Still Uncertain
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Patent and Regulatory Challenges in AI’s Use in Life Sciences
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
Managing Labeling Needs to Become as Easy as Using a Banking App
A lot of promises are made by organizations about making systems more intuitive, convenient and user-centric, but in reality most improvements tend to be designed to meet regulatory or internal system needs rather than better serve the people who use them. The user experience needs to be modernized, especially in heavily regulated industries where inaccurate or non-compliant labeling is laden with risk.
Will the 2020 Elections Affect MedTech Investment? Maybe
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
The Convergence in Healthcare and How Small and Large MedTech Companies Must Adjust
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
